Director, Market Access & Reimbursement - Diagnostics

Remote; San Francisco (CA); Hybrid; USD 180,000 - 280,000; Full time

Job summary

DELFI Diagnostics, Inc. invites a Director/Senior Director of Market Access & Reimbursement to own the US access strategy end-to-end for DELFI's product lines.

Translate clinical and health-economic evidence into coding, coverage, and payment strategies to place our early cancer detection tests into patient care. This role is hands-on, requiring deep CMS/Medicare expertise, strategic payer engagement, and the ability to build a scalable market access function while collaborating with Medical

Qualifications

• Bachelor's degree with extensive market access experience in diagnostics, medical devices, or pharma.
• Deep CMS/Medicare expertise and familiarity with payer pathways.
• Proven ability to secure coverage with CMS and U.S. payers.
• Strong CPT/HCPCS/ICD-10 coding and payer policy knowledge.
• Hands-on leader capable of starting without a large team.

Responsibilities

• Own and execute U.S. market access and reimbursement strategy across product lines.
• Serve as subject-matter expert on CMS/Medicare processes and pricing pathways.
• Develop coverage strategies with Medicare, regional payers, and VA.
• Build formal reimbursement plans for new launches and value-based options.
• Collaborate with Medical Affairs, Clinical, Regulatory, and HE to align evidence needs.
• Ensure compliant payer engagement with Legal/Compliance.
• Identify health-economic evidence gaps and translate needs into studies.
• Engage payers and health technology assessment bodies to shape coverage policies.
• Establish tools, processes, and networks to scale the function and build a team.

Skills

CMS/Medicare expertise

Payer policy knowledge

Coding (CPT/HCPCS/ICD-10)

Strategic reimbursement planning

Stakeholder negotiation

Communication & influencing

Education

Bachelor's degree

Master's degree

Job description

DELFI Diagnostics, Inc. invites a Director/Senior Director of Market Access & Reimbursement to own the US access strategy end-to-end for DELFI's product lines.

Translate clinical and health-economic evidence into coding, coverage, and payment strategies to place our early cancer detection tests into patient care. This role is hands-on, requiring deep CMS/Medicare expertise, strategic payer engagement, and the ability to build a scalable market access function while collaborating with Medical